Basf Se Corporation

Basf Aktiengesellschaft

Silke Gebert

Karl Kolter

Maximilian Angel

Michael Schönherr

Kathrin Meyer-Böhm

Angelika Maschke

Bernhard Fussnegger

Michael Klemens Mueller

Felicitas Guth

Matthias Karl

Michael Klemens Müller

Yoshitaka Katsuno

A finely divided binder in powder form consisting of a polyethylene glycol-polyvinyl alcohol graft polymer particles, wherein the particles have an average particle size D[4,3] in the range of from 10 to 70 &#x3bc;m.

Dry-binders for tablets based on polyethylene glycol-polyvinyl alcohol graft polymers, the production and use thereof

Pharmaceutical coatings obtained from coating compositions based on film-forming copolymers of N,N-diethylaminoethyl methacrylate (DEAEMA) and methyl methacrylate (MMA) comprising a weight ratio of DEAEMA:MMA in the range of 35:65 to 55:45, where the copolymers are present partially neutralized with C-C-dicarboxylic acids.

Production of pharmaceutical protective coatings with good resistance in a neutral environment

Described are solid dispersions of hydrophobic active ingredients and cationic copolymers of N,N-diethylaminoethyl methacrylate and methyl methacrylate in a weight ratio of the monomers of from 35:65 to 55:45. Also described are the preparation and use of such solid dispersions for pharmaceutical dosage forms.

Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers

Pharmaceutical formulation in the form of agglomerates comprising

Pharmaceutical formulation for the production of rapidly disintegrating tablets

Rapidly disintegrating, solid coated dosage form comprising a solid core consisting of at least 60% by weight of an auxiliary mixture, up to 40% by weight of at least one active ingredient, and optionally further auxiliaries, coated with at least one film coating comprising completely or partially hydrolyzed, rapidly water-soluble polyether-vinyl ester graft polymers, methods for the production thereof, and their use.

Rapidly disintegrating, solid coated dosage form

Pharmaceutical formulation in the form of agglomerates comprising A) an excipient content composed of 

Pharmaceutical formulation in the form of compacts comprising

The invention relates to polymer dispersions or polymer solutions that are given antibacterial and fungicidal properties by metal ions of group Ib of the Periodic table. According to the invention, a) the polymer dispersions or polymer solutions are not produced using controllers that contain thiol groups, b) the metal ions have been introduced by means of an electrochemical process and c) said dispersions or solutions do not contain any active quantity of organic biocides.

Growing community of inventors

Grünstadt, Germany

Silke Gebert